Shares Outstanding (Quarterly) Chart

View Shares Outstanding (Quarterly) for VERU.
Upgrade now.
Sep '18
Jan '19
May '19
 
285.00
270.00
255.00
240.00
View Shares Outstanding (Quarterly) Chart
Start Trial

Historical Shares Outstanding (Quarterly) Data

View and export this data back to 1998. Start Trial.
Date Value
June 30, 2026 17.05M
March 31, 2026 16.05M
December 31, 2025 16.05M
September 30, 2025 14.65M
June 30, 2025 14.65M
March 31, 2025 146.58M
December 31, 2024 146.38M
September 30, 2024 14.64M
June 30, 2024 14.64M
March 31, 2024 14.64M
December 31, 2023 14.64M
September 30, 2023 91.78M
June 30, 2023 89.24M
March 31, 2023 8.258M
December 31, 2022 8.062M
September 30, 2022 8.269M
June 30, 2022 80.13M
March 31, 2022 80.07M
December 31, 2021 80.05M
September 30, 2021 79.97M
June 30, 2021 79.85M
March 31, 2021 79.68M
December 31, 2020 71.91M
September 30, 2020 69.86M
June 30, 2020 69.86M
Date Value
March 31, 2020 65.70M
December 31, 2019 65.04M
September 30, 2019 65.04M
June 30, 2019 64.82M
March 31, 2019 62.78M
December 31, 2018 62.62M
September 30, 2018 55.28M
June 30, 2018 54.74M
March 31, 2018 5.351M
December 31, 2017 5.351M
September 30, 2017 5.321M
June 30, 2017 31.34M
March 31, 2017 31.34M
December 31, 2016 31.34M
September 30, 2016 29.09M
June 30, 2016 29.05M
March 31, 2016 29.05M
December 31, 2015 29.03M
September 30, 2015 29.01M
June 30, 2015 28.76M
March 31, 2015 28.82M
December 31, 2014 28.81M
September 30, 2014 28.78M
June 30, 2014 28.89M
March 31, 2014 28.88M

Shares Outstanding Definition

The volume of stock shares issued by the company and in the hands of the public. This number entails how much is being traded in the open market. A decreasing shares outstanding over time may be the result of company buybacks. Companies frequently make stock buybacks and retire those buybacks as treasury stock.

Read full definition.

Shares Outstanding (Quarterly) Range, Past 5 Years

View Shares Outstanding (Quarterly) Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

Shares Outstanding (Quarterly) Benchmarks

View Shares Outstanding (Quarterly) Benchmarks
Start Trial
ANI Pharmaceuticals, Inc. 22.97M
Corcept Therapeutics, Inc. 107.92M
Johnson & Johnson 2.408B
Eli Lilly & Co. 941.50M
Lexicon Pharmaceuticals, Inc. 444.94M